Eli Lilly and Company LLY

$ 905.03 -1.93%

Annual report 2025
added 02-12-2026

Eli Lilly and Company DIO Ratio 2011-2026 | LLY

Annual DIO Ratio Eli Lilly and Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
352	290	260	226	196	239	247	233	268	230	250	203	218	201	166

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
352	166	238

Quarterly DIO Ratio Eli Lilly and Company

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
379	344	293	265	300	238	236	248	-	111	124	171	-	247	175	186	-	274	297	269	227	248	259	252	250	245	229	254	302	350	357	382	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
382	111	259

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 333.39	-1.77 %	$ 43.7 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.68	1.4 %	$ 1.01 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	-	-	$ 399 M	USA
	Aquestive Therapeutics AQST	120	$ 4.24	2.17 %	$ 453 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.58	-2.03 %	$ 3.13 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.49	0.68 %	$ 397 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain